Quinolone
Showing 1 - 25 of 90
Staphylococcus Aureus and Escherichia Coli From Humans, Chicken
Not yet recruiting
- Drug Resistance, Microbial
- (no location specified)
Dec 7, 2022
Complicated Urinary Tract Infection, Acute Pyelonephritis Trial (Sulopenem Etzadroxil/Probenecid)
Available
- Complicated Urinary Tract Infection
- Acute Pyelonephritis
- Sulopenem Etzadroxil/Probenecid
- (no location specified)
Mar 29, 2022
Carbapenem and Quinolone Resistance in Klebsiella Pneumoniae
Unknown status
- Antibiotic Resistant Strain
-
Assiut, EgyptAssiut University
Jan 13, 2020
Complicated Urinary in Real-life Conditions.
Unknown status
- Complicated Urinary Tract Infection
- Drug: Intravenous fosfomycin
- Drug: Intravenous quinolone or beta-lactam
-
Córdoba, Spain
- +1 more
Nov 13, 2019
Acute Lymphoblastic Leukaemia - Category Trial in Leicester (Ciprofloxacin, Antibiotic)
Recruiting
- Acute Lymphoblastic Leukaemia - Category
-
Leicester, United KingdomLeicester Royal Infirmary
Jul 5, 2022
Acute Ischemic Stroke Trial (Levofloxacin, Levofloxacin simulant)
Not yet recruiting
- Acute Ischemic Stroke
- Levofloxacin
- Levofloxacin simulant
- (no location specified)
Apr 5, 2023
Acute Ischemic Stroke Trial (Levofloxacin, Levofloxacin simulant)
Not yet recruiting
- Acute Ischemic Stroke
- Levofloxacin
- Levofloxacin simulant
- (no location specified)
Feb 14, 2023
Acute Ischemic Stroke Trial (Levofloxacin, Levofloxacin simulant)
Not yet recruiting
- Acute Ischemic Stroke
- Levofloxacin
- Levofloxacin simulant
- (no location specified)
Feb 14, 2023
Idiopathic Pulmonary Fibrosis Trial in Assiut (Azithromycin, Methylprednisolone)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
-
Assiut, EgyptAssiut university-Faculty of Medicine
May 2, 2023
Helicobacter Pylori Infection, Helicobacter Pylori Infection, Susceptibility to Trial in Karachi (Sequential Regimen:
Completed
- Helicobacter Pylori Infection
- Helicobacter Pylori Infection, Susceptibility to
- Sequential Regimen: Levofloxacin 500 mg BID, Amoxicillin 1 gm BID, omeprazole 20 mg BID for first five days followed by Levofloxacin 500 mgBID, Tinidazole 500 mg BID, Omeprazole 20 mg BID
- Triple Regimen: Moxifloxacin 400mg OD, Amoxicillin 1 gm BID, Omeprazole 20mgBID
-
Karachi, Sindh, PakistanJamal Noor Hospital, Karachi
May 8, 2023
Ascites Infection Trial in Cairo (Rifaximin 550 milligram Oral Tablet [XIFAXAN])
Completed
- Ascites Infection
- Rifaximin 550 milligram Oral Tablet [XIFAXAN]
-
Cairo, Egyptfaculty of medicine Ain Shams university
Nov 17, 2022
Spontaneous Bacterial Peritonitis Trial in Foggia (Rifaximin, Norfloxacin)
Active, not recruiting
- Spontaneous Bacterial Peritonitis
-
Foggia, ItalyOspedali Riuniti Foggia
Feb 15, 2021
MDS Trial in Saint Louis (vosaroxin, Azacitidine)
Active, not recruiting
- Myelodysplastic Syndromes
-
Saint Louis, MissouriWashington University School of Medicine
Mar 23, 2022
Human Microbiome, Antibiotic Resistant Infection, Nursing Homes Trial in Seville (PROA Experimental, PROA Control)
Completed
- Human Microbiome
- +2 more
- PROA Experimental
- PROA Control
-
Seville, SpainVirgen del Rocío University Hospital
Mar 15, 2022
Retinitis Pigmentosa Trial (1.5 x 10^6 UC-MSC + CM, 5 x 10^6 UC-MSC + CM)
Not yet recruiting
- Retinitis Pigmentosa
- 1.5 x 10^6 UC-MSC + CM
- 5 x 10^6 UC-MSC + CM
- (no location specified)
Jun 11, 2023
Neisseria Gonorrhoeae Infection Trial in Seattle (Ciprofloxacin 500 mg)
Recruiting
- Neisseria Gonorrhoeae Infection
- Ciprofloxacin 500 mg
-
Seattle, WashingtonPublic Health -- Seattle & King County Sexual Health Clinic
Mar 9, 2022
Quinolone Resistance Among ESBL Producing Klebsiella Species
Completed
- Quinolone Resistance
- +3 more
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
Jun 13, 2018
Irritable Bowel Syndrome Trial in Krynki, Stawiszyn (Vivatlac Synbiotikum)
Recruiting
- Irritable Bowel Syndrome
- Vivatlac Synbiotikum
-
Krynki, Poland
- +1 more
Feb 15, 2023
MDR-TB Trial in Worldwide (Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine)
Active, not recruiting
- MDR-TB
- Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
- +9 more
-
Addis Ababa, Ethiopia
- +12 more
Oct 12, 2022
COPD Exacerbation Acute Trial in China (Sitafloxacin, Moxifloxacin Hydrochloride)
Recruiting
- COPD Exacerbation Acute
- Sitafloxacin
- Moxifloxacin Hydrochloride
-
Changsha, China
- +12 more
Sep 6, 2022
Urinary Tract Infection Trial in United States (Fosfomycin tromethamine, Levofloxacin)
Terminated
- Urinary Tract Infection
- Fosfomycin tromethamine
- Levofloxacin
-
Sylmar, California
- +11 more
Nov 19, 2020
Helicobacter Infections, Resistance Bacterial, Gastritis H Pylori Trial (Rifabutin, Amoxicillin, Esomeprazole)
Not yet recruiting
- Helicobacter Infections
- +2 more
- Rifabutin
- +4 more
- (no location specified)
Mar 9, 2021
Triage Test for All Oral DR-TB Regimen (TRiAD Study)
Recruiting
- Drug Resistant Tuberculosis
- +3 more
- Xpert® MTB/XDR
-
Gulele, Addis Ababa, Ethiopia
- +3 more
Jun 13, 2022
Urinary Tract Infections Trial in Bahawalpur (Crano-cure, Ciprofloxacin 500 mg)
Completed
- Urinary Tract Infections
- Crano-cure
- Ciprofloxacin 500 mg
-
Bahawalpur, Punajb, Pakistan
- +1 more
Jun 23, 2021